NCT00094159View on ClinicalTrials.gov

Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2004

Conditions
Neoplasms
Interventions
DRUG

SNS-595

Trial Locations (4)

Unknown

Arizona Cancer Center, Scottsdale

Arizona Cancer Center, Tucson

Stanford University Medical Center, Stanford

Duke University Medical Center, Durham

Sponsors
All Listed Sponsors
lead

Sunesis Pharmaceuticals

INDUSTRY